Buprenorphine Maintenance Protocol - 1 - Tabular View

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Buprenorphine Maintenance Protocol - 1

This study has been completed.

Study NCT00000205. Last updated on November 3, 2005. Information provided by National Institute on Drug Abuse (NIDA)

This Tabular View shows the required WHO registration data elements as marked by ^†

Descriptive Information Fields

Brief Title ^†

Buprenorphine Maintenance Protocol - 1

Official Title ^†

Buprenorphine Maintenance Protocol

Brief Summary

The purpose of this study is to compare the efficacy of buprenorphine versus methadone.

Detailed Description

Study Phase

Phase III

Study Type ^†

Interventional

Study Design ^†

Treatment, Double-Blind, Placebo Control

Primary Outcome Measure ^†

Retention
Opiate use
Opiate craving
Adverse events

Secondary Outcome Measure ^†

Condition ^†

Opioid-Related Disorders

Intervention ^†

Drug: Buprenorphine

MEDLINE PMIDs

Links

Recruitment Information Fields

Recruitment Status ^†

Completed

Enrollment ^†

Start Date ^†

October 1990

Completion Date

Eligibility Criteria ^†

Inclusion Criteria:

M/F ages 21-50. Opiate dependence according to DSM-IV criteria. Self-reported use within the last 30 days. Agreeable to conditions of study and signed informed consent.

Exclusion Criteria:

Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and /or nursing women. Dependence on ETOH or benzodiazepines or other sedative/hynotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe

Gender

Both

Ages

21 Years to 50 Years

Accepts Healthy Volunteers

Contacts ^††

Location Countries ^†

United States

Administrative Information Fields

NCT ID ^†

NCT00000205

Organization ID

NIDA-06082-1

Secondary IDs ^††

R18-06082-1

Study Sponsor ^†

National Institute on Drug Abuse (NIDA)

Collaborators ^††

Investigators ^†

Principal Investigator:

Walter Ling, M.D.

Friends Research Institute, Inc.

Information Provided By

National Institute on Drug Abuse (NIDA)

Verification Date

October 1992

First Received Date ^†

September 20, 1999

Last Updated Date

November 3, 2005

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.